[1] Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J]. Lancet Oncol, 2009, 10(5):459-466. [2] Liu X, Fan D. The epithelial-mesenchymal transition and cancer stem cells:functional and mechanistic links[J]. Curr Pharm Des, 2015, 21(10):1279-1291. [3] Sato R, Semba T, Saya H, et al. Concise review:Stem cells and epithelial-mesenchymal transition in cancer:Biological implications and therapeutic targets[J]. Stem Cells, 2016, 34(8):1997-2007. [4] Dragu DL, Necula LG, Bleotu C, et al. Therapies targeting cancer stem cells:Current trends and future challenges[J]. World J Stem Cells, 2015, 7(9):1185-1201. [5] Mladinich M, Ruan D, Chan CH. Tackling cancer stem cells via inhibition of EMT transcription factors[J]. Stem Cells Int,2016, 2016:5285892. [6] Prieto-García E, Díaz-García CV, García-Ruiz I, et al. Epithelial-to-mesenchymal transition in tumor progression[J]. Med Oncol, 2017, 34(7):122. [7] 宋扬, 赵丽艳, 陈勇, 等. TGFβ1对胶质瘤U87细胞上皮-间质转化的诱导作用[J]. 吉林大学学报:医学版, 2016, 42(6):1087-1091. [8] Song Y, Chen Y, Li Y, et al. Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway[J]. Oncotarget, 2018, 9(6):7023-7035. [9] Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4):704-715. [10] Pirozzi G, Tirino V, Camerlingo R, et al. Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line[J]. PLoS One, 2011, 6(6):e21548. [11] Fan F, Samuel S, Evans KW, et al. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells[J]. Cancer Med, 2012, 1(1):5-16. [12] Singla M, Kumar A, Bal A, et al. Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells[J]. Cancer Cell Int, 2018, 18:57. [13] Gürsel DB, Shin BJ, Burkhardt JK, et al. Glioblastoma stem-like cells-Biology and therapeutic implications[J]. Cancers (Basel), 2011, 3(2):2655-2666. [14] Pastrana E, Silva-Vargas V, Doetsch F. Eyes wide open:A critical review of sphere-formation as an assay for stem cells[J]. Cell Stem Cell, 2011, 8(5):486-498. [15] Lombardo Y, de Giorgio A, Coombes CR, et al. Mammosphere formation assay from human breast cancer tissues and cell lines[J]. J Vis Exp, 2015, 97:e52671-e52675. [16] Ota I, Masui T, Kurihara M, et al. Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells[J]. Oncol Rep, 2016, 35(1):261-266. [17] Bhattacharya R, Mustafi SB, Street M, et al. Bmi-1:At the crossroads of physiological and pathological biology[J]. Genes Dis, 2015, 2(3):225-239. [18] Song WS, Yang YP, Huang CS, et al. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells[J]. J Chin Med Assoc, 2016, 79(10):538-545. [19] Mao DD, Gujar AD, Mahlokozera T, et al. A CDC20-APC/SOX2 signaling axis regulates human glioblastoma stem-like cells[J]. Cell Rep, 2015, 11(11):1809-1821. [20] 王莹,宋凡.富亮氨酸胶质瘤失活1蛋白抗体相关自身免疫性脑炎6例临床分析[J].中国实用内科杂志,2018,38(8):749-752. |